Clinical Trial Update: Efficacy in Walked Distance of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass (EMERALD) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing indacaterol with tiotropium in women with COPD due to biomass reports on walking distance efficacy (EMERALD; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Onbrez Breezhaler (indacaterol) (indacaterol)
• Spiriva Inhalation Powder (tiotropium) (tiotropium)

Snippet

Sponsor: National Institute of Respiratory Diseases, Mexico | Conditions: COPD | Phase 4 | Status: COMPLETED